New drug combo may replace harsh transplant for hodgkin lymphoma patients
NCT ID NCT05502250
First seen Mar 09, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests a new drug called tislelizumab combined with chemotherapy for people whose Hodgkin lymphoma has returned or not responded to first treatment. The goal is to see if this approach works as well as the standard intensive chemo and stem cell transplant. About 75 adults with confirmed Hodgkin lymphoma will receive the drug combo, and those who achieve complete remission will continue on tislelizumab alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BE-Bruxelles-STLUC
Brussels, Belgium
-
DK-Aarhus N-AUH
Aarhus, Denmark
-
DK-Copenhagen-RIGSHOSPITALET
Copenhagen, Denmark
-
DK-Odense-OUH
Odense, Denmark
-
NL-Amersfoort-MEANDERMC
Amersfoort, Netherlands
-
NL-Amsterdam-AMC
Amsterdam, Netherlands
-
NL-Arnhem-RIJNSTATE
Arnhem, Netherlands
-
NL-Den Haag-HAGA
The Hague, Netherlands
-
NL-Eindhoven-MAXIMAMC
Eindhoven, Netherlands
-
NL-Goes-ADRZ
Goes, Netherlands
-
NL-Groningen-UMCG
Groningen, Netherlands
-
NL-Hoofddorp-SPAARNEGASTHUIS
Hoofddorp, Netherlands
-
NL-Leeuwarden-MCL
Leeuwarden, Netherlands
-
NL-Maastricht-MUMC
Maastricht, Netherlands
-
NL-Rotterdam-ERASMUSMC
Rotterdam, Netherlands
Conditions
Explore the condition pages connected to this study.